Acadia Healthcare Company, Inc. (ACHC) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2025)
ACHC's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
ACHC Revenue Analysis (2014–2025)
As of March 1, 2026, Acadia Healthcare Company, Inc. (ACHC) generated trailing twelve-month (TTM) revenue of $3.31 billion, reflecting solid growth of +6.1% year-over-year. The most recent quarter (Q4 2025) recorded $821.5 million in revenue, down 3.5% sequentially.
Looking at the longer-term picture, ACHC's 5-year compound annual growth rate (CAGR) stands at +9.7%, indicating steady revenue expansion. The company achieved its highest annual revenue of $3.31 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows ACHC's business is primarily driven by United States Facilities (100%). With over half of revenue concentrated in United States Facilities, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including HCA (+7.1% YoY), THC (+3.1% YoY), and MPW (-2.7% YoY), ACHC has underperformed the peer group in terms of revenue growth. Compare ACHC vs HCA →
Peer Comparison
Compare ACHC's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ACHCCurrent | $3.3B | +6.1% | +9.7% | 11.7% | |
| HCA | $75.6B | +7.1% | +8.0% | 15.8% | |
| THC | $21.3B | +3.1% | +3.9% | 16.5% | |
| MPW | $972M | -2.7% | -4.9% | - | |
| ARDT | $6.0B | +10.9% | +23.2% | 6.8% | |
| CYH | $12.5B | -1.2% | +1.2% | 11.9% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $3.31B | +5.0% | $583.4M | 17.6% | $388.0M | 11.7% |
| 2024 | $3.15B | +7.7% | $712.0M | 22.6% | $522.3M | 16.6% |
| 2023 | $2.93B | +12.2% | $682.6M | 23.3% | $506.6M | 17.3% |
| 2022 | $2.61B | +12.8% | $2.51B | 96.2% | $467.7M | 17.9% |
| 2021 | $2.31B | +10.7% | $2.22B | 96.1% | $414.5M | 17.9% |
| 2020 | $2.09B | +4.1% | $2.00B | 95.8% | $0 | - |
| 2019 | $2.01B | -33.3% | $815.5M | 40.6% | $661.6M | 32.9% |
| 2018 | $3.01B | +6.2% | $1.23B | 41.0% | $412.7M | 13.7% |
| 2017 | $2.84B | +0.9% | $1.19B | 41.8% | $437.9M | 15.4% |
| 2016 | $2.81B | +56.6% | $1.15B | 41.0% | $445.1M | 15.8% |
See ACHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ACHC Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ACHC vs AGIO
See how ACHC stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is ACHC's revenue growth accelerating or slowing?
ACHC maintains +6.1% revenue growth, in line with its 5-year CAGR of +9.7%. TTM revenue stands at $3.3B. Growth rate remains consistent with historical average.
What is ACHC's long-term revenue growth rate?
Acadia Healthcare Company, Inc.'s 5-year revenue CAGR of +9.7% reflects the sustained expansion pattern. Current YoY growth of +6.1% is near this long-term average.
How is ACHC's revenue distributed by segment?
ACHC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.